SHSE:688575 (China)
Â
Class A
Â¥
9.29
-0.070 (-0.75%)
Jul 20
Business Description
Shenzhen YHLO Biotech Co Ltd
ISIN : CNE100005204
Share Class Description:
SHSE:688575: Class ATotal Employee Number:
1,664Compare
Compare
Traded in other countries / regions
688575.China Index Membership
SSE Composite Index IPO Date
2021-05-17Description
Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.71 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | 7.45 | |||||
Interest Coverage | 9.72 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.27 | |||||
Beneish M-Score | -2.93 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.8 | |||||
3-Year EBITDA Growth Rate | -33.3 | |||||
3-Year EPS without NRI Growth Rate | -56.3 | |||||
3-Year FCF Growth Rate | -60.9 | |||||
3-Year Book Growth Rate | 3.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 127.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 9.55 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.8 | |||||
9-Day RSI | 52.76 | |||||
14-Day RSI | 47.77 | |||||
3-1 Month Momentum % | -36.85 | |||||
6-1 Month Momentum % | -39.93 | |||||
12-1 Month Momentum % | -38.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.19 | |||||
Quick Ratio | 1.53 | |||||
Cash Ratio | 0.73 | |||||
Days Inventory | 374.61 | |||||
Days Sales Outstanding | 112.51 | |||||
Days Payable | 127.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.22 | |||||
Dividend Payout Ratio | 1.93 | |||||
3-Year Dividend Growth Rate | -19.3 | |||||
Forward Dividend Yield % | 0.22 | |||||
5-Year Yield-on-Cost % | 0.22 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | -1.68 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 65.53 | |||||
Operating Margin % | 12.19 | |||||
Net Margin % | 1.74 | |||||
EBITDA Margin % | 7.04 | |||||
FCF Margin % | 5.28 | |||||
OCF Margin % | 28.26 | |||||
ROE % | 1.15 | |||||
ROA % | 0.73 | |||||
ROIC % | 4.8 | |||||
3-Year ROIIC % | -129.27 | |||||
ROC (Joel Greenblatt) % | 4.95 | |||||
ROCE % | 3.78 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 185.8 | |||||
Forward PE Ratio | 26.54 | |||||
PE Ratio without NRI | 85.23 | |||||
PEG Ratio | 31.57 | |||||
PS Ratio | 3.15 | |||||
PB Ratio | 1.96 | |||||
Price-to-Tangible-Book | 2.08 | |||||
Price-to-Free-Cash-Flow | 65.87 | |||||
Price-to-Operating-Cash-Flow | 12.08 | |||||
EV-to-EBIT | 44.21 | |||||
EV-to-EBITDA | 44.21 | |||||
EV-to-Revenue | 3.11 | |||||
EV-to-FCF | 58.94 | |||||
Price-to-GF-Value | 0.64 | |||||
Price-to-Projected-FCF | 2.15 | |||||
Price-to-Graham-Number | 2.81 | |||||
| Price-to-Net-Current-Asset-Value | 13.27 | |||||
Earnings Yield (Greenblatt) % | 2.26 | |||||
FCF Yield % | 1.78 | |||||
Forward Rate of Return (Yacktman) % | -21.89 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shenzhen YHLO Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,790.639 | ||
| EPS (TTM) (Â¥) | 0.05 | ||
| Beta | 0.8446 | ||
| 3-Year Sharpe Ratio | -0.61 | ||
| 3-Year Sortino Ratio | -0.78 | ||
| Volatility % | 31.65 | ||
| 14-Day RSI | 47.77 | ||
| 14-Day ATR (Â¥) | 0.394985 | ||
| 20-Day SMA (Â¥) | 9.0845 | ||
| 12-1 Month Momentum % | -38.76 | ||
| 52-Week Range (Â¥) | 8.34 - 17 | ||
| Shares Outstanding (Mil) | 571.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shenzhen YHLO Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shenzhen YHLO Biotech Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.021000 Cash Dividend | 2026-06-12 | 9.48 (-0.73%) | ||
| CNY 0.210000 Cash Dividend | 2025-06-27 | 14.78 (-0.47%) | ||
| 1.4:1 Stock Split | 2022-06-02 | 21.31 (-0.86%) |
Show
Entries
Shenzhen YHLO Biotech Co Ltd Frequently Asked Questions
What is Shenzhen YHLO Biotech Co Ltd(SHSE:688575)'s stock price today?
The current price of SHSE:688575 is ¥9.29. The 52 week high of SHSE:688575 is ¥17.00 and 52 week low is ¥8.34.
When is next earnings date of Shenzhen YHLO Biotech Co Ltd(SHSE:688575)?
The next earnings date of Shenzhen YHLO Biotech Co Ltd(SHSE:688575) is .
Does Shenzhen YHLO Biotech Co Ltd(SHSE:688575) pay dividends? If so, how much?
The Dividend Yield %  of Shenzhen YHLO Biotech Co Ltd(SHSE:688575) is 0.22% (As of Today), Highest Dividend Payout Ratio of Shenzhen YHLO Biotech Co Ltd(SHSE:688575) was 1.93. The lowest was 0.24. And the median was 0.85. The  Forward Dividend Yield % of Shenzhen YHLO Biotech Co Ltd(SHSE:688575) is 0.22%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Shenzhen YHLO Biotech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers